Categories for Case Studies

Value messaging & launch support

A US-based biotech with a market-leading portfolio of drugs to treat rare and severe diseases, producing an innovative, chemotherapeutic agent... View More

Ultra-orphan drug pricing strategy

A small-cap, biotechnology company producing a biologic molecule for ultra-orphan indication; licensed and launched in US and Japan, applying for... View More